Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$1.9 - $4.18 $53,116 - $116,856
27,956 Added 2541.45%
29,056 $70,000
Q1 2022

May 16, 2022

SELL
$3.54 - $8.3 $22,939 - $53,784
-6,480 Reduced 85.49%
1,100 $4,000
Q4 2021

Feb 08, 2022

BUY
$7.69 - $19.66 $49,877 - $127,514
6,486 Added 592.87%
7,580 $60,000
Q3 2021

Nov 15, 2021

BUY
$12.22 - $21.28 $13,246 - $23,067
1,084 Added 10840.0%
1,094 $21,000
Q2 2021

Sep 13, 2021

BUY
$9.0 - $15.94 $90 - $159
10 New
10 $0

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.